CLARIO
{{Short description|American technology company}}
{{Not to be confused with|Clairo}}
{{Infobox company
| name = CLARIO
| logo =
| caption =
| type = Private
| traded_as =
| genre =
| fate =
| predecessor =
| successor =
| foundation = {{Start date|1972}}
| founder =
| defunct =
| location_city = Philadelphia
| location_country = U.S.
| location =
| locations =
| area_served =
| key_people = Christopher Fikry, M.D.(CEO){{Cite web|url=https://clario.com/about/newsroom/new-clario-ceo-christopher-fikry-m-d-to-lead-company-through-next-phase-of-growth-and-innovation/|title=New Clario CEO, Christopher Fikry, M.D., to lead company through next phase of growth and innovation|date=1 July 2022}}
| industry = Healthcare
Clinical Research
Pharmaceutical Service
Medical Technology
| products =
| services =
| revenue = $350 million to $400 million (USD) per year
| operating_income =
| net_income =
| aum =
| assets =
| equity =
| owner = Privately Owned
| num_employees = 1001 to 5000 employees (2024)
| website = {{URL|clario.com}}
| parent =
| divisions =
| subsid =
| footnotes =
| intl =
}}
CLARIO, formerly ERT and Bioclinica,{{Cite web|url=https://clario.com/about/newsroom/ert-and-bioclinica-become-clario/|title = ERT and Bioclinica become Clario|date = 3 November 2021}} is a technology company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. It offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient-reported outcomes (ePRO) in multiple modalities across all phases of clinical research.{{Cite web |url=http://www.ert.com/Home/AboutUs/ERTMilestones/tabid/61/Default.aspx |title=ERT Milestones |access-date=2009-11-11 |archive-url=https://web.archive.org/web/20100502024214/http://www.ert.com/Home/AboutUs/ERTMilestones/tabid/61/Default.aspx |archive-date=2010-05-02 |url-status=dead }}
History
In 2008, ERT acquired Biosigna, a Munich-based company, which specialized in biomedical signal processing.
In 2009, ERT ended its foray into the electronic data capture (EDC) business as ERT sold its EDC division for approximately $2.025 million of OmniComm shares.{{cite web |title=OmniComm buys eResearch Technology's data capture unit |url=http://philadelphia.bizjournals.com/philadelphia/stories/2009/06/22/daily19.html |website=American City Business Journals |date=2009-06-24 |archive-url=https://web.archive.org/web/20090715074413/http://philadelphia.bizjournals.com:80/philadelphia/stories/2009/06/22/daily19.html? |archive-date=2009-07-15 |url-status=live |last1=Key |first1=Peter}}
In 2010, ERT acquired the Research Services Division of the CareFusion Corporation. This nearly doubled the company in size and brought a new service line and enhancements to its two current service offerings; Respiratory Services, specializing in centralized spirometry, Multi-Mode ePRO for patient reported outcomes, and enhanced Cardiac Safety Solutions. Along with the acquisition, ERT now has the capability to design and construct their own clinical diagnostic devices from a manufacturing facility in Estenfeld, Germany.{{Cite web|url=http://ert.investorroom.com/index.php?s=43&item=379|title=You searched for 43}}
In 2010, the then-current CEO of ERT was replaced on an interim basis by Joel Morganroth, M.D.{{Cite web|url=http://www.realwire.com/releases/ERT-Announces-the-Appointment-of-Joel-Morganroth-MD-as-Interim-CEO|title=ERT | ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO|date=21 December 2010}}{{Cite web|url=https://www.yourobserver.com/article/ringling-college-15-million-donation-morganroth|title=Ringling College receives record-breaking $15 million gift | Arts and Entertainment|date=29 January 2018}}{{Cite web|url=https://www.srqmagazine.com/srq-daily/2018-01-30/7732_Ringling-College-Receives-Landmark-Gift--Endowment-for-VR-Department-Head?share=1|title=Ringling College Receives Landmark Gift, Endowment for VR Department Head - SRQ Daily Jan 30, 2018}}
In 2011, Jeffrey S. Litwin, M.D. was appointed ERT's new president and chief executive officer. Litwin joined ERT in 2000 as senior vice president and chief medical officer and was subsequently promoted in December 2005 to executive vice president and chief medical officer. Dr. Litwin oversaw ERT's global cardiac safety operations for seven years.{{Citation needed|date=September 2023}}
On July 3, 2012, ERT announced that Genstar Capital LLC of San Francisco acquired ERT in a take-private transaction valued at approximately $400 million.{{Citation needed|date=September 2023}}
In November 2014, ERT acquired eClinical Insights (eCI), a provider of cloud-based clinical trials management software.{{Cite web|url=https://www.ert.com/uncategorized/ert-announces-acquisition-of-eclinical-insights/|title = ERT Announces Acquisition of eClinical Insights|date = 6 November 2014}}
On February 27, 2015, ERT acquired PHT Corporation (PHT).{{Cite web|url=https://www.ert.com/uncategorized/ert-completes-acquisition-of-pht-corporation/|title = ERT Completes Acquisition of PHT Corporation|date = 11 May 2015}}
In March 2016, ERT was acquired by Nordic Capital, a private healthcare investment firm for about $1.8 Billion.{{Cite web|url=https://www.nordiccapital.com/news/nordic-capital-fund-viii-and-novo-as-announce-the-closing-of-the-acquisition-of-ert/|title = Nordic Capital Fund VIII and Novo A/S announce the closing of the acquisition of ERT | Nordic Capital}}
In December 2016, ERT acquired Exco InTouch, a provider of patient engagement, data capture and digital health solutions.
In May 2017, ERT acquired ImageIQ, clinical trial biomedical imaging and analysis company.{{Cite web|url=https://www.ert.com/news/ert-acquires-imaging-solution-from-cleveland-clinic/|title = ERT Acquires Imaging Solution from Cleveland Clinic|date = 9 May 2017}}
In September 2017, ERT acquired Biomedical Systems (BMS), a provider of imaging as well as cardiac safety and respiratory data collection solutions.{{Cite web|url=https://www.ert.com/news/ert-acquires-biomedical-systems/|title=ERT Acquires Biomedical Systems|date=8 September 2017}}
In December 2017, ERT acquired iCardiac Technologies, a global provider of centralized cardiac safety, respiratory, and electronic clinical outcome assessment (eCOA) solutions that accelerate clinical research.{{Cite web|url=https://www.ert.com/news/ert-acquires-icardiac-tecnologies/|title = ERT Acquires iCardiac Technologies|date = 4 December 2017}}
In June 2020, ERT acquired APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers.{{Cite web | url=https://www.outsourcing-pharma.com/Article/2020/06/23/ERT-acquires-wearable-trial-technology-company | title=ERT Acquires Wearable Technology Specialist}}
In December 2020, ERT announced a merger with Bioclinica, a global clinical trial end-point solutions company, with Joe Eazor to be its head.{{Citation needed|date=September 2023}} In November 2021, following the merger, the company renamed itself to Clario.{{Cite web|url=https://clario.com/about/newsroom/ert-and-bioclinica-become-clario/|title = ERT and Bioclinica become Clario|date = 3 November 2021}}
In April 2024, it was announced Clario had acquired the Leuven, Belgium-headquartered AI medical technology company, ArtiQ.{{Cite web |last=Nunwick |first=Alice |date=2024-04-03 |title=Clario acquires ArtiQ AI for clinical trials |url=https://www.verdict.co.uk/clario-acquires-artiq-ai-for-clinical-trials/ |access-date=2024-04-03 |website=Verdict |language=en-US}}
References
{{reflist}}
{{Contract research organization}}
Category:Companies based in Philadelphia